Rus Eng
Main / Company's news / Epilepsy Day: New possibilities of therapy in Focus

Epilepsy Day: New possibilities of therapy in Focus

2 March 2015

Russian Conference “Association of Epileptologists and Patients” took place on February 27, 2015 in the hotel “Holiday Inn Moskovskye Vorota” in St. Petersburg. The theme of the conference was: “Remission of epilepsy. Modern possibilities and achievements in Russia.”

The conference was held with the support of the Committee for Public Health of St. Petersburg, the St. Petersburg V.M. Bekhterev Psychoneurological Research Institute, the Institute of the Human Brain n.a. N.P.Behtereva and Palms of the World association. GEROPHARM, one of the leading Russian pharmaceutical manufacturers, actively participated in the conference. Neurology is a traditional area of specialization of the company. In 2013 GEROPHARM manufactured some modern, high quality and affordable generics, including Levetinol® which is used in epilepsy treatment.

Epilepsy is one of the most widespread onset of nervous system disorders. The incidence of epilepsy is 30-50 per 100,000 people (0.05%). Number of patients with epilepsy in the world is about 30 million people. In Europe there are 3 million patients, in the United States - 4 million, in Russia - 500 thousand. Every year in Russia 54 thousand patients fall ill with epilepsy.

The conference featured presentations of leading experts. They were focused on current problems of this socially significant disease treatment and its prevention among adults and children.

In their reports Maxim A. Yamin (main epileptologist of the Russian Ministry of Health, head of the regional epilepsy centre in Rostov-on-Don) and Kira V. Voronkova, (Professor and Doctor of Medical Science of the Pirogov Russian National Research Medical University and vice president of Moscow Association of Epileptologists and Patients) described and justified the experience of using Levetinol as the first-line therapy of focal epilepsy in Russia. They also presented the analysis of a clinical case in which Levetinol demonstrated its high efficacy and safety.

An exhibition was also held during the conference. Leading Russian and foreign manufacturers of pharmaceutical products and medical devices took part in it. GEROPHARM had its own booth where the company showed a portfolio of drug products and production capabilities.

Background

Epilepsy Day officially celebrated on the second Monday in February.

At the age of nine Cassidy Megan from Scotland, already experienced the neglect of others, came up to celebrate “Purple Day”. With the help of this event more people could know about this disease, no longer wary of her and would be able to support patients with epilepsy. On March 26, 2008, with the assistance of the Epilepsy Association of Nova Scotia, it was decided to celebrate Purple Day and European Epilepsy Day. The following year more than 100 non-governmental organizations participated in its celebration. In February medical and public organisations celebrate Purple Day carrying out various activities. Their goal is to increase public awareness of epilepsy and teach how to perform first aid for an epilepsy seizure.

Purple or lavender is the international colour of epilepsy, because it has a positive effect on the nervous system and reduces anxiety.

Epilepsy Day in Russia

For the fist time Epilepsy Day was celebrated in Russia on March 10, 2011. International Epilepsy Day will be celebrated for the first time in 2015.

You are a health care professional?

Go up